Clinical Trials Browser

Phase NA × Has results × Sunitinib × Clear all

Breast Neoplasms

NCT00428220 2019-06-27

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

NCT01502228 2019-03-05

PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Phase NA Terminated

14 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell

NCT00537056 2017-06-14

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

Phase NA Completed

17 enrolled 6 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00849186 2015-02-06

Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

Phase NA Completed

20 enrolled 6 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00443534 2013-05-24

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Phase NA Completed

123 enrolled 6 charts

Tumor-Agnostic

Neoplasms

NCT00798889 2013-01-21

Rollover Protocol for Prior SU011248 Protocols

Phase NA Completed

314 enrolled 6 charts

Other solid neoplasm

Solid Tumors

Clinical Trials

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Rollover Protocol for Prior SU011248 Protocols